The pharmaceutical industry's pursuit of more effective treatments has led to a significant focus on Highly Potent Active Pharmaceutical Ingredients (HPAPIs). These compounds, known for their efficacy at low doses, are integral to therapies in oncology and other critical areas. However, their potency necessitates stringent measures in development and manufacturing to ensure safety and...